JP2008500988A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500988A5 JP2008500988A5 JP2007513837A JP2007513837A JP2008500988A5 JP 2008500988 A5 JP2008500988 A5 JP 2008500988A5 JP 2007513837 A JP2007513837 A JP 2007513837A JP 2007513837 A JP2007513837 A JP 2007513837A JP 2008500988 A5 JP2008500988 A5 JP 2008500988A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- corticosteroid
- receptor antagonist
- muscarinic receptor
- antagonism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003246 corticosteroid Substances 0.000 claims description 17
- 229960001334 corticosteroids Drugs 0.000 claims description 7
- -1 flunizolide Chemical compound 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims description 4
- 229960004436 budesonide Drugs 0.000 claims description 4
- 229960003957 dexamethasone Drugs 0.000 claims description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 3
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229940092705 beclomethasone Drugs 0.000 claims description 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims description 2
- 229960003728 ciclesonide Drugs 0.000 claims description 2
- PLCQGRYPOISRTQ-FCJDYXGNSA-L dexamethasone sodium phosphate Chemical compound [Na+].[Na+].C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP([O-])([O-])=O)(O)[C@@]1(C)C[C@@H]2O PLCQGRYPOISRTQ-FCJDYXGNSA-L 0.000 claims description 2
- 229960002344 dexamethasone sodium phosphate Drugs 0.000 claims description 2
- 150000001993 dienes Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229960002714 fluticasone Drugs 0.000 claims description 2
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims description 2
- 229960001664 mometasone Drugs 0.000 claims description 2
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims description 2
- 229960005294 triamcinolone Drugs 0.000 claims description 2
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims description 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims 9
- 239000003149 muscarinic antagonist Substances 0.000 claims 9
- 208000023504 respiratory system disease Diseases 0.000 claims 8
- 230000008485 antagonism Effects 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 241001465754 Metazoa Species 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 claims 2
- 229950000210 beclometasone dipropionate Drugs 0.000 claims 2
- 229940124748 beta 2 agonist Drugs 0.000 claims 2
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 108060006698 EGF receptor Proteins 0.000 claims 1
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 claims 1
- 102100037346 Substance-P receptor Human genes 0.000 claims 1
- UWBJXLMHPBMEJX-ZXKIDFLWSA-M [(3R)-1-(1-phenylethyl)-1-azoniabicyclo[2.2.2]octan-3-yl] 9H-xanthene-9-carboxylate bromide Chemical group [Br-].C1CC([C@H](C2)OC(=O)C3C4=CC=CC=C4OC4=CC=CC=C43)CC[N+]12C(C)C1=CC=CC=C1 UWBJXLMHPBMEJX-ZXKIDFLWSA-M 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 229940043355 kinase inhibitor Drugs 0.000 claims 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 claims 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 229940044601 receptor agonist Drugs 0.000 claims 1
- 239000000018 receptor agonist Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 125000002723 alicyclic group Chemical group 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- ZMPRRFPMMJQXPP-UHFFFAOYSA-N 2-sulfobenzoic acid Chemical class OC(=O)C1=CC=CC=C1S(O)(=O)=O ZMPRRFPMMJQXPP-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- LBWGVMHQXJFUCE-UHFFFAOYSA-N CC1=CC=C(C)OC1 Chemical compound CC1=CC=C(C)OC1 LBWGVMHQXJFUCE-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229940126083 M3 antagonist Drugs 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- ZLLPOXZGRDWOKF-LBFFRULKSA-N [(3R)-1-(1-phenylethyl)-1-azoniabicyclo[2.2.2]octan-3-yl] 9H-xanthene-9-carboxylate Chemical compound C1CC([C@H](C2)OC(=O)C3C4=CC=CC=C4OC4=CC=CC=C43)CC[N+]12C(C)C1=CC=CC=C1 ZLLPOXZGRDWOKF-LBFFRULKSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical class OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229950010765 pivalate Drugs 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229960002794 prednicarbate Drugs 0.000 description 1
- FNPXMHRZILFCKX-KAJVQRHHSA-N prednicarbate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O FNPXMHRZILFCKX-KAJVQRHHSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200401312A ES2257152B1 (es) | 2004-05-31 | 2004-05-31 | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| ESP200401312 | 2004-05-31 | ||
| EP2005001969 | 2005-02-24 | ||
| EPPCT/EP2005/001969 | 2005-02-24 | ||
| GBPCT/GB2005/000722 | 2005-02-25 | ||
| GB2005000740 | 2005-02-25 | ||
| GB2005000722 | 2005-02-25 | ||
| GBPCT/GB2005/000740 | 2005-02-25 | ||
| PCT/EP2005/005838 WO2005115464A1 (en) | 2004-05-31 | 2005-05-31 | Combinations comprising antimuscarinic agents and corticosteroids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008500988A JP2008500988A (ja) | 2008-01-17 |
| JP2008500988A5 true JP2008500988A5 (enExample) | 2008-07-10 |
| JP5049120B2 JP5049120B2 (ja) | 2012-10-17 |
Family
ID=34956036
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513836A Expired - Fee Related JP4966192B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびβ−アドレナリンアゴニストを含む組合せ剤 |
| JP2006508319A Expired - Lifetime JP4928258B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびベータ−アドレナリンアゴニストを含む組み合わせ |
| JP2007513839A Expired - Fee Related JP5032984B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびコルチコステロイドを含む組合せ剤 |
| JP2007513838A Expired - Fee Related JP5107701B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびｐｄｅ４阻害剤を含む組合せ剤 |
| JP2007513835A Expired - Fee Related JP5133054B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびｐｄｅ４阻害剤を含む組合せ剤 |
| JP2007513837A Expired - Fee Related JP5049120B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびコルチコステロイドを含む組合せ剤 |
| JP2011215066A Pending JP2012012407A (ja) | 2004-05-31 | 2011-09-29 | 抗ムスカリン剤およびベータ−アドレナリンアゴニストを含む組み合わせ |
| JP2012152733A Expired - Fee Related JP5538485B2 (ja) | 2004-05-31 | 2012-07-06 | 抗ムスカリン剤およびｐｄｅ４阻害剤を含む組合せ剤 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513836A Expired - Fee Related JP4966192B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびβ−アドレナリンアゴニストを含む組合せ剤 |
| JP2006508319A Expired - Lifetime JP4928258B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびベータ−アドレナリンアゴニストを含む組み合わせ |
| JP2007513839A Expired - Fee Related JP5032984B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびコルチコステロイドを含む組合せ剤 |
| JP2007513838A Expired - Fee Related JP5107701B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびｐｄｅ４阻害剤を含む組合せ剤 |
| JP2007513835A Expired - Fee Related JP5133054B2 (ja) | 2004-05-31 | 2005-05-31 | 抗ムスカリン剤およびｐｄｅ４阻害剤を含む組合せ剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011215066A Pending JP2012012407A (ja) | 2004-05-31 | 2011-09-29 | 抗ムスカリン剤およびベータ−アドレナリンアゴニストを含む組み合わせ |
| JP2012152733A Expired - Fee Related JP5538485B2 (ja) | 2004-05-31 | 2012-07-06 | 抗ムスカリン剤およびｐｄｅ４阻害剤を含む組合せ剤 |
Country Status (45)
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100471016B1 (ko) * | 1996-08-07 | 2005-07-12 | 스미또모 가가꾸 가부시키가이샤 | 살충성에어로졸조성물및이를제조하기위한살충조성물 |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US20050026948A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| KR20060052912A (ko) * | 2003-07-29 | 2006-05-19 | 베링거 인겔하임 인터내셔날 게엠베하 | 항콜린제와 스테로이드의 배합물 및 흡입으로 호흡기장애를 치료하기 위한 이의 용도 |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| PT1765404E (pt) * | 2004-05-31 | 2009-03-31 | Almirall Lab | Combinações compreendendo agentes antimuscarínicos e agonistas beta-adrenérgicos |
| WO2006085689A1 (ja) * | 2005-02-10 | 2006-08-17 | Oncolys Biopharma, Inc. | テロメライシン併用抗癌剤 |
| PL2098248T3 (pl) * | 2005-12-21 | 2012-11-30 | Meda Pharma Gmbh & Co Kg | Kombinacja antycholinergików, glukokortykoidów i beta2-agonistów do leczenia chorób zapalnych |
| CA2643130A1 (en) * | 2006-02-22 | 2007-08-30 | Valorisation Recherche Hscm, Limited Partnership | Compounds and methods of treating disorders associated with activation of metachromatic cells |
| US8007790B2 (en) | 2006-04-03 | 2011-08-30 | Stowers Institute For Medical Research | Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases |
| TW200815054A (en) * | 2006-06-19 | 2008-04-01 | Otsuka Pharma Co Ltd | Methods of using a thiazole derivative |
| CN102772411A (zh) * | 2006-07-05 | 2012-11-14 | 奈科明有限责任公司 | 用于治疗炎症性肺部疾病的HMG-CoA还原酶抑制剂与磷酸二酯酶4抑制剂的组合 |
| AU2007275931B2 (en) | 2006-07-19 | 2011-06-16 | Astrazeneca Ab | Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| ES2298049B1 (es) * | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
| HRP20110556T1 (hr) * | 2007-02-21 | 2011-09-30 | Almirall | Novi postupci |
| CA2608561A1 (en) * | 2007-10-29 | 2009-04-29 | Carl Paluszkiewicz | Motorcycle wind deflector accessory support |
| EP2080523A1 (en) * | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Compositions comprising an antimuscarinic and a long-acting beta-agonist |
| EP2080508A1 (en) * | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Dry powder formulation comprising an anticholinergic drug |
| EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| CN103622962A (zh) * | 2008-03-14 | 2014-03-12 | 大塚制药株式会社 | 制剂组合物在制备治疗以mmp-2及/或mmp-9为起因的纤维症的药物中的应用 |
| KR101605576B1 (ko) | 2008-05-27 | 2016-03-22 | 아스트라제네카 아베 | 페녹시피리디닐아미드 유도체 및 ｐｄｅ４ 매개 질환 상태의 치료에서의 그의 용도 |
| GB0814729D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
| EP2156847A1 (en) * | 2008-08-19 | 2010-02-24 | Sanofi-Aventis | New combination of active ingredients containing an alpha1-antagonist and a PDE 4 inhibitor. |
| ES2739352T3 (es) | 2009-02-26 | 2020-01-30 | Glaxo Group Ltd | Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| HUE044653T2 (hu) | 2009-07-22 | 2019-11-28 | PureTech Health LLC | Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| EA024922B1 (ru) | 2010-08-03 | 2016-11-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| EP2718281B1 (en) | 2011-06-10 | 2015-09-09 | Chiesi Farmaceutici S.p.A. | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| HRP20151317T1 (hr) | 2011-06-10 | 2016-01-01 | Chiesi Farmaceutici S.P.A. | Spojevi koji pokazuju aktivnost prema antagonistima muskarinskog receptora i beta2 adrenergiäśnog receptora |
| HUE069624T2 (hu) * | 2012-01-25 | 2025-03-28 | Chiesi Farm Spa | Kortikoszteroidot és béta-adrenerg szert tartalmazó száraz porkészítmény inhalálással történõ beadásra |
| CA2869849A1 (en) | 2012-04-13 | 2013-10-17 | Glaxosmithkline Intellectual Property Development Limited | Aggregate particles comprising nanoparticulate drug particles of umeclidinium bromide, vilanterol trifenatate and fluticasone furoate |
| US9156833B2 (en) | 2012-07-16 | 2015-10-13 | Barry University, Inc. | Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
| RU2661877C2 (ru) | 2012-12-06 | 2018-07-20 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета-2-адренергических рецепторов |
| MX369311B (es) * | 2012-12-06 | 2019-11-05 | Chiesi Farm Spa | Compuestos con actividad antagonista de los receptores muscarinicos y actividad agonista del receptor beta2 adrenergico. |
| GB201222679D0 (en) | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
| PT2968312T (pt) | 2013-03-15 | 2018-04-19 | Verona Pharma Plc | Combinação de fármacos |
| CN106029931A (zh) * | 2013-10-09 | 2016-10-12 | 怡康医疗股份有限公司 | 用于医疗装置的改善的金属合金 |
| WO2015071192A1 (en) | 2013-11-15 | 2015-05-21 | Rhodia Operations | Polyamide compositions for metal coating and metal components coated with the same |
| RU2019110980A (ru) * | 2014-01-10 | 2019-08-26 | Эфиммьюн Лимитед | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |
| TWI703138B (zh) | 2015-02-12 | 2020-09-01 | 義大利商吉斯藥品公司 | 具有蕈毒鹼受體拮抗劑及β２腎上腺素受體促效劑活性之化合物 |
| AR104828A1 (es) | 2015-06-01 | 2017-08-16 | Chiesi Farm Spa | COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARÍNICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO |
| EP3383867B1 (en) | 2015-12-03 | 2021-04-14 | Chiesi Farmaceutici S.p.A. | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| EP3400214B1 (en) * | 2016-01-08 | 2024-03-13 | Theron Pharmaceuticals, Inc. | Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives |
| WO2018011090A1 (en) | 2016-07-13 | 2018-01-18 | Chiesi Farmaceutici S.P.A. | Hydroxyquinolinone compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| EP3625232B1 (en) | 2017-05-19 | 2021-06-23 | Council of Scientific and Industrial Research | Substituted methanopyrido [2, 1-a]isoindolones as machr modulators for treating various associated pathophysiological conditions and process for preparation thereof |
| WO2019147824A1 (en) | 2018-01-26 | 2019-08-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
| BR112021005802B1 (pt) | 2018-09-28 | 2022-02-15 | Karuna Therapeutics, Inc | Composição farmacêutica oral |
| WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| IT202000006442A1 (it) * | 2020-03-27 | 2021-09-27 | Genetic S P A | Budesonide 21-phosphate salts and pharmaceutical compositions containing the same |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| US11504332B2 (en) * | 2021-03-23 | 2022-11-22 | Vk Research Associates Inc. | Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof |
| CN117999072A (zh) * | 2021-09-23 | 2024-05-07 | 库拉森疗法公司 | β肾上腺素能激动剂和其使用方法 |
Family Cites Families (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1219606A (en) * | 1968-07-15 | 1971-01-20 | Rech S Et D Applic Scient Soge | Quinuclidinol derivatives and preparation thereof |
| FR2414044A1 (fr) * | 1978-01-10 | 1979-08-03 | Pharmindustrie | Nouveaux derives d'aza-1 bicyclo(2,2,2) octane, utilisables comme medicaments |
| IT7920688U1 (it) | 1979-02-05 | 1980-08-05 | Chiesi Paolo | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore |
| DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
| FR2539135B1 (fr) * | 1983-01-11 | 1986-02-28 | Essilor Int | Hydrogels de polyurethane et procede de fabrication |
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
| US4675326A (en) * | 1985-05-08 | 1987-06-23 | Gabriel Amitai | Bisquaternary antidotes |
| US4843074A (en) * | 1988-05-17 | 1989-06-27 | Marion Laboratories, Inc. | 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts |
| DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
| US5290815A (en) * | 1989-09-07 | 1994-03-01 | Glaxo Group Limited | Treatment of inflammation and allergy |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
| US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
| GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
| WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
| US5507281A (en) * | 1990-08-30 | 1996-04-16 | Boehringer Ingelheim Kg | Device for initiating a mechanical switching operation in synchronism with the breathing |
| DE4027391A1 (de) * | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
| EP0640354B1 (en) | 1990-09-26 | 2001-12-05 | Pharmachemie B.V. | Whirl chamber powder inhaler |
| GB9026025D0 (en) * | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
| US5290539A (en) * | 1990-12-21 | 1994-03-01 | Minnesota Mining And Manufacturing Company | Device for delivering an aerosol |
| DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
| AU650953B2 (en) * | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
| DE4239402A1 (de) * | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
| ES2129117T3 (es) * | 1992-12-09 | 1999-06-01 | Boehringer Ingelheim Pharma | Formulaciones en disolucion en forma de aerosol medicinales estabilizadas. |
| PL173090B1 (pl) | 1992-12-18 | 1998-01-30 | Schering Corp | Inhalator do sproszkowanych lekarstw |
| GB9412434D0 (en) * | 1994-06-21 | 1994-08-10 | Inmos Ltd | Computer instruction compression |
| MX9707864A (es) | 1995-04-14 | 1997-11-29 | Glaxo Wellcome Inc | Inhalador de dosis medida por salmeterol. |
| DE69617431T2 (de) | 1995-06-21 | 2002-08-01 | Asta Medica Ag | Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator |
| DE19528145A1 (de) * | 1995-08-01 | 1997-02-06 | Boehringer Ingelheim Kg | Neue Arzneimittel und ihre Verwendung |
| DE19536902A1 (de) * | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
| US6150415A (en) * | 1996-08-13 | 2000-11-21 | The Regents Of The University Of California | Epoxide hydrolase complexes and methods therewith |
| US5885834A (en) * | 1996-09-30 | 1999-03-23 | Epstein; Paul M. | Antisense oligodeoxynucleotide against phosphodiesterase |
| US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| ITMI981671A1 (it) * | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| WO2000007567A1 (de) * | 1998-08-04 | 2000-02-17 | Jago Research Ag | Medizinische aerosolformulierungen |
| DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
| GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
| DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US7214687B2 (en) * | 1999-07-14 | 2007-05-08 | Almirall Ag | Quinuclidine derivatives and medicinal compositions containing the same |
| GB9928311D0 (en) * | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
| US6410563B1 (en) * | 1999-12-22 | 2002-06-25 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| FR2803378B1 (fr) * | 1999-12-29 | 2004-03-19 | Valeo Climatisation | Echangeur de chaleur a tubes a plusieurs canaux, en particulier pour vehicule automobile |
| US20030018061A1 (en) * | 2000-01-28 | 2003-01-23 | Kohei Ogawa | Novel remedies with the use of beta 3 agonist |
| US6924292B2 (en) * | 2000-03-23 | 2005-08-02 | Takeda Chemical Industries, Ltd. | Furoisoquinoline derivatives, process for producing the same and use thereof |
| GB0008485D0 (en) * | 2000-04-07 | 2000-05-24 | Glaxo Group Ltd | Pharmaceutical compositions |
| GB0009605D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medicaments |
| GB0009592D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
| GB0009606D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
| GB0009583D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| UA73986C2 (uk) * | 2000-05-22 | 2005-10-17 | К'Єзі Фармачеутічі С.П.А. | АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ |
| US20020052312A1 (en) * | 2000-05-30 | 2002-05-02 | Reiss Theodore F. | Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists |
| WO2002000241A2 (en) * | 2000-06-28 | 2002-01-03 | Aventis Pharma S.A. | Compositions and methods for regulating the cell cycle using a ki gene or polypeptide |
| US6852728B2 (en) * | 2000-10-14 | 2005-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them |
| US6706726B2 (en) * | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
| EP1333830A2 (de) | 2000-10-31 | 2003-08-13 | Boehringer Ingelheim Pharma GmbH & Co.KG | Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden |
| US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US20020193393A1 (en) * | 2001-03-07 | 2002-12-19 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| US20030158196A1 (en) * | 2002-02-16 | 2003-08-21 | Boehringer Ingelheim Pharma Gmbh Co. Kg | Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors |
| US7776315B2 (en) * | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| US6608054B2 (en) * | 2001-03-20 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics and endothelin antagonists |
| US6620438B2 (en) * | 2001-03-08 | 2003-09-16 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists |
| US20020122773A1 (en) * | 2000-12-20 | 2002-09-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and dopamine agonists |
| US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| US20020193392A1 (en) * | 2000-11-13 | 2002-12-19 | Christel Schmelzer | Pharmaceutical compositions based on tiotropium salts of salts of salmeterol |
| DE10056104A1 (de) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
| PT1353919E (pt) * | 2000-12-28 | 2006-11-30 | Almirall Prodesfarma Ag | Novos derivados de quinuclidina e composições medicinais contendo os mesmos |
| US20020179087A1 (en) * | 2001-02-01 | 2002-12-05 | Karl-Heinz Bozung | Pharmaceutical compositions containing an oxitropium salt and a betamimetic |
| US20020189610A1 (en) * | 2001-02-01 | 2002-12-19 | Karl-Heinz Bozung | Pharmaceutical compositions containing an ipratropium salt and a betamimetic |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| US20030216329A1 (en) * | 2001-04-24 | 2003-11-20 | Robinson Cynthia B. | Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| JP2004530705A (ja) * | 2001-05-25 | 2004-10-07 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 閉塞性気道疾患及びその他の炎症性疾患を治療するためのｐｄｅ４インヒビター及びチオトロピウム又はその誘導体の組み合わせ |
| GB0115181D0 (en) * | 2001-06-20 | 2001-08-15 | Glaxo Group Ltd | Novel use |
| US20030018019A1 (en) | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| DE10130371A1 (de) | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
| US6919325B2 (en) * | 2001-09-14 | 2005-07-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| US6974803B2 (en) * | 2001-12-06 | 2005-12-13 | Pfizer Inc | Pharmaceutical combination |
| US6790856B2 (en) * | 2002-01-31 | 2004-09-14 | Boehringer Ingelheim Pharma Kg | Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| US6756508B2 (en) * | 2002-03-04 | 2004-06-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Cinnamic acid salts, processes for their preparation, and their use as medicaments |
| US7094788B2 (en) * | 2002-04-13 | 2006-08-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| ES2206021B1 (es) * | 2002-04-16 | 2005-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de pirrolidinio. |
| ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| PL219032B1 (pl) * | 2002-05-17 | 2015-03-31 | Novartis Ag | Kompozycja farmaceutyczna zawierająca alskiren, amlodypinę i hydrochlortiazyd, kombinacja zawierająca te składniki, zastosowanie wspomnianej kombinacji oraz zestaw handlowy zawierający wspomnianą kombinację |
| CN101700247A (zh) * | 2002-06-12 | 2010-05-05 | 埃匹吉尼斯医药有限公司 | 利用脱氢表雄酮甾体及抗毒蕈碱药物治疗呼吸道疾病及肺病的组合物、制剂和试剂盒 |
| EP1546099B1 (en) * | 2002-07-08 | 2008-12-31 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| US20040058950A1 (en) * | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| WO2004039968A1 (ja) * | 2002-10-30 | 2004-05-13 | Japan Science And Technology Agency | 骨髄由来の不死化樹状細胞株 |
| ES2211315B1 (es) | 2002-11-12 | 2005-10-16 | Almirall Prodesfarma, S.A. | Nuevos compuestos triciclicos. |
| HRP20050572A2 (en) * | 2002-11-27 | 2006-08-31 | Altana Pharma Ag | Pde4 and pde3/4 inhibitors for use in the treatment of cachexia |
| ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
| DE10307759B3 (de) * | 2003-02-19 | 2004-11-18 | Schering Ag | Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel |
| US20040184995A1 (en) * | 2003-03-17 | 2004-09-23 | Yamanouchi Pharmaceutical Co., Ltd. | Novel dry powder inhalation for lung-delivery and manufacturing method thereof |
| US20060147382A1 (en) * | 2003-03-28 | 2006-07-06 | Altana Pharma Ag | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| CA2519682A1 (en) * | 2003-03-28 | 2004-10-07 | Altana Pharma Ag | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| US20050026886A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor |
| US20050026887A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a steroid |
| BRPI0413129A (pt) * | 2003-07-29 | 2006-10-03 | Boehringer Ingelheim Int | medicamentos para inalação compreendendo betamiméticos e anticolinérgico |
| US20050026948A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| ATE526967T1 (de) * | 2003-07-31 | 2011-10-15 | Boehringer Ingelheim Int | Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum |
| US20050025718A1 (en) * | 2003-07-31 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
| ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| PL1713471T3 (pl) * | 2004-02-06 | 2012-06-29 | Meda Pharma Gmbh & Co Kg | Kombinacja środków antycholinergicznych i inhibitorów fosfodiesterazy typu 4 do leczenia chorób oddechowych |
| ES2309705T3 (es) * | 2004-02-06 | 2008-12-16 | MEDA PHARMA GMBH & CO. KG | Nueva combinacion de anticolinergico y beta-mimeticos para el tratamiento de enfermedades respiratorias. |
| SI1713473T1 (sl) * | 2004-02-06 | 2013-06-28 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB |
| US7375935B2 (en) * | 2004-04-12 | 2008-05-20 | Leviton Manufacturing Co., Inc. | Ground fault circuit interrupter with enhanced radio frequency interference suppression |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| US20060189551A1 (en) * | 2004-10-04 | 2006-08-24 | Duke University | Combination therapies for fungal pathogens |
-
2004
- 2004-05-31 ES ES200401312A patent/ES2257152B1/es not_active Expired - Fee Related
-
2005
- 2005-05-31 CN CNA2005800176934A patent/CN1960761A/zh active Pending
- 2005-05-31 ES ES05750538T patent/ES2322280T5/es not_active Expired - Lifetime
- 2005-05-31 NL NL1029151A patent/NL1029151C2/nl not_active IP Right Cessation
- 2005-05-31 JP JP2007513836A patent/JP4966192B2/ja not_active Expired - Fee Related
- 2005-05-31 US US11/628,521 patent/US20070232637A1/en not_active Abandoned
- 2005-05-31 GR GR20050100269A patent/GR1006045B/el active IP Right Grant
- 2005-05-31 AT AT05750538T patent/ATE424847T1/de active
- 2005-05-31 PE PE2005000613A patent/PE20060292A1/es not_active Application Discontinuation
- 2005-05-31 US US11/628,523 patent/US20080051378A1/en not_active Abandoned
- 2005-05-31 SI SI200530611T patent/SI1763369T1/sl unknown
- 2005-05-31 BR BRPI0511666-0A patent/BRPI0511666A/pt not_active IP Right Cessation
- 2005-05-31 PE PE2008000713A patent/PE20081650A1/es active IP Right Grant
- 2005-05-31 PL PL10010080T patent/PL2292267T3/pl unknown
- 2005-05-31 ZA ZA200600261A patent/ZA200600261B/xx unknown
- 2005-05-31 ES ES05751702T patent/ES2318498T3/es not_active Expired - Lifetime
- 2005-05-31 WO PCT/EP2005/005841 patent/WO2005115467A1/en not_active Ceased
- 2005-05-31 SI SI200531895T patent/SI2292267T1/sl unknown
- 2005-05-31 EP EP14171380.0A patent/EP2774622B1/en not_active Expired - Lifetime
- 2005-05-31 ES ES07019644T patent/ES2348558T3/es not_active Expired - Lifetime
- 2005-05-31 ES ES200650034A patent/ES2293849B2/es not_active Expired - Fee Related
- 2005-05-31 KR KR1020067025298A patent/KR101174677B1/ko not_active Expired - Lifetime
- 2005-05-31 JP JP2006508319A patent/JP4928258B2/ja not_active Expired - Lifetime
- 2005-05-31 CN CNA200580017692XA patent/CN101018566A/zh active Pending
- 2005-05-31 EP EP08014478A patent/EP2002843A3/en not_active Withdrawn
- 2005-05-31 EP EP14171384.2A patent/EP2774623B1/en not_active Expired - Lifetime
- 2005-05-31 BR BRPI0511662A patent/BRPI0511662B8/pt active IP Right Grant
- 2005-05-31 UA UAA200612581A patent/UA89184C2/ru unknown
- 2005-05-31 UA UAA200612583A patent/UA89185C2/ru unknown
- 2005-05-31 MC MC2511A patent/MC200083A1/fr unknown
- 2005-05-31 ES ES07019646T patent/ES2348680T3/es not_active Expired - Lifetime
- 2005-05-31 HU HU0600139A patent/HUP0600139A3/hu unknown
- 2005-05-31 EP EP10003016A patent/EP2210613A1/en not_active Withdrawn
- 2005-05-31 WO PCT/EP2005/005836 patent/WO2005115462A1/en not_active Ceased
- 2005-05-31 ME MEP-2014-434A patent/ME02134B/me unknown
- 2005-05-31 DK DK05751702T patent/DK1763369T3/da active
- 2005-05-31 RS RSP-2009/0045A patent/RS50717B/sr unknown
- 2005-05-31 PT PT05750538T patent/PT1763368E/pt unknown
- 2005-05-31 DE DE602005013220T patent/DE602005013220D1/de not_active Expired - Lifetime
- 2005-05-31 AU AU2005247107A patent/AU2005247107B2/en not_active Ceased
- 2005-05-31 TW TW094117908A patent/TWI404530B/zh not_active IP Right Cessation
- 2005-05-31 EP EP10010079A patent/EP2319538A3/en not_active Withdrawn
- 2005-05-31 EP EP08014479A patent/EP2002844B1/en not_active Expired - Lifetime
- 2005-05-31 CN CN200580017685XA patent/CN1960759B/zh not_active Expired - Lifetime
- 2005-05-31 GB GB0526502A patent/GB2419819B/en not_active Expired - Lifetime
- 2005-05-31 EP EP05747758A patent/EP1761280A1/en not_active Withdrawn
- 2005-05-31 UY UY28933A patent/UY28933A1/es not_active Application Discontinuation
- 2005-05-31 FR FR0505473A patent/FR2870744B1/fr not_active Expired - Lifetime
- 2005-05-31 US US11/141,428 patent/US20050267078A1/en not_active Abandoned
- 2005-05-31 ME MEP-2009-570A patent/ME02779B/me unknown
- 2005-05-31 BR BRPI0511669-4A patent/BRPI0511669A/pt not_active IP Right Cessation
- 2005-05-31 LU LU91214A patent/LU91214B1/fr active Protection Beyond IP Right Term
- 2005-05-31 RU RU2006147250A patent/RU2404771C3/ru active Protection Beyond IP Right Term
- 2005-05-31 ME MEP-2009-369A patent/ME01680B/me unknown
- 2005-05-31 RU RU2006147268/15A patent/RU2385721C2/ru not_active IP Right Cessation
- 2005-05-31 UA UAA200612580A patent/UA89183C2/ru unknown
- 2005-05-31 RS RSP-2010/0378A patent/RS51386B/sr unknown
- 2005-05-31 JP JP2007513839A patent/JP5032984B2/ja not_active Expired - Fee Related
- 2005-05-31 DK DK07019644.9T patent/DK1891973T3/da active
- 2005-05-31 EP EP10010080.9A patent/EP2292267B1/en not_active Expired - Lifetime
- 2005-05-31 AT AT05751702T patent/ATE417627T1/de active
- 2005-05-31 MX MXPA06013847A patent/MXPA06013847A/es active IP Right Grant
- 2005-05-31 CA CA2569077A patent/CA2569077C/en not_active Expired - Fee Related
- 2005-05-31 ES ES10010080.9T patent/ES2505329T3/es not_active Expired - Lifetime
- 2005-05-31 CH CH00085/06A patent/CH696962A5/fr not_active IP Right Cessation
- 2005-05-31 RU RU2006142331/15A patent/RU2373935C2/ru not_active IP Right Cessation
- 2005-05-31 AT AT07019644T patent/ATE474600T1/de active
- 2005-05-31 EP EP05751702A patent/EP1763369B1/en not_active Expired - Lifetime
- 2005-05-31 PT PT05751702T patent/PT1763369E/pt unknown
- 2005-05-31 AU AU2005247103A patent/AU2005247103B2/en not_active Ceased
- 2005-05-31 CA CA2568566A patent/CA2568566C/en not_active Expired - Fee Related
- 2005-05-31 AR ARP050102229A patent/AR049066A1/es unknown
- 2005-05-31 DE DE602005022497T patent/DE602005022497D1/de not_active Expired - Lifetime
- 2005-05-31 US US11/141,427 patent/US20050288266A1/en not_active Abandoned
- 2005-05-31 DK DK05750538.0T patent/DK1763368T4/da active
- 2005-05-31 US US11/141,169 patent/US20050267135A1/en not_active Abandoned
- 2005-05-31 DK DK05748688T patent/DK1765404T3/da active
- 2005-05-31 BR BRPI0511656-2A patent/BRPI0511656A/pt not_active IP Right Cessation
- 2005-05-31 MY MYPI20052478A patent/MY142095A/en unknown
- 2005-05-31 CA CA002533061A patent/CA2533061C/en not_active Expired - Lifetime
- 2005-05-31 CN CNA2005800176953A patent/CN1960762A/zh active Pending
- 2005-05-31 PL PL05751702T patent/PL1763369T3/pl unknown
- 2005-05-31 CN CNA2005800176949A patent/CN1972716A/zh active Pending
- 2005-05-31 PT PT07019644T patent/PT1891973E/pt unknown
- 2005-05-31 EP EP08014859A patent/EP2002845A3/en not_active Withdrawn
- 2005-05-31 DE DE602005011803T patent/DE602005011803D1/de not_active Expired - Lifetime
- 2005-05-31 MX MXPA06004124A patent/MXPA06004124A/es active IP Right Grant
- 2005-05-31 ME MEP-2009-371A patent/ME01670B/me unknown
- 2005-05-31 IT IT001021A patent/ITMI20051021A1/it unknown
- 2005-05-31 NZ NZ551668A patent/NZ551668A/en not_active IP Right Cessation
- 2005-05-31 CN CN201210251471.0A patent/CN102755321B/zh not_active Expired - Fee Related
- 2005-05-31 JP JP2007513838A patent/JP5107701B2/ja not_active Expired - Fee Related
- 2005-05-31 EP EP09011129A patent/EP2138188A1/en not_active Withdrawn
- 2005-05-31 CN CN2011100241324A patent/CN102085373A/zh active Pending
- 2005-05-31 PL PL05750538T patent/PL1763368T5/pl unknown
- 2005-05-31 UA UAA200612584A patent/UA86976C2/ru unknown
- 2005-05-31 EP EP05750538.0A patent/EP1763368B2/en not_active Expired - Lifetime
- 2005-05-31 PE PE2008000712A patent/PE20081649A1/es active IP Right Grant
- 2005-05-31 HR HRP20090215TT patent/HRP20090215T4/hr unknown
- 2005-05-31 EP EP05748688A patent/EP1765404B1/en not_active Expired - Lifetime
- 2005-05-31 PL PL05748688T patent/PL1765404T3/pl unknown
- 2005-05-31 BR BRPI0511667-8A patent/BRPI0511667A/pt active Search and Examination
- 2005-05-31 RS RS20090197A patent/RS50787B2/sr unknown
- 2005-05-31 SI SI200531114T patent/SI1891973T1/sl unknown
- 2005-05-31 SI SI200530690T patent/SI1763368T2/sl unknown
- 2005-05-31 MX MXPA06013848A patent/MXPA06013848A/es active IP Right Grant
- 2005-05-31 NZ NZ551667A patent/NZ551667A/en not_active IP Right Cessation
- 2005-05-31 RS RSP20140434 patent/RS53529B1/sr unknown
- 2005-05-31 UA UAA200612576A patent/UA89182C2/ru unknown
- 2005-05-31 KR KR1020137005271A patent/KR20130027586A/ko not_active Ceased
- 2005-05-31 WO PCT/EP2005/005840 patent/WO2005115466A1/en not_active Ceased
- 2005-05-31 EP EP07019644A patent/EP1891973B1/en not_active Expired - Lifetime
- 2005-05-31 JP JP2007513835A patent/JP5133054B2/ja not_active Expired - Fee Related
- 2005-05-31 HR HR20090107T patent/HRP20090107T3/xx unknown
- 2005-05-31 BR BRPI0511660-0A patent/BRPI0511660A/pt not_active IP Right Cessation
- 2005-05-31 BE BE2005/0268A patent/BE1016608A5/fr not_active IP Right Cessation
- 2005-05-31 CN CNA2005800176915A patent/CN1960760A/zh active Pending
- 2005-05-31 NZ NZ544539A patent/NZ544539A/en not_active IP Right Cessation
- 2005-05-31 PT PT100100809T patent/PT2292267E/pt unknown
- 2005-05-31 US US11/628,522 patent/US20080045565A1/en not_active Abandoned
- 2005-05-31 UA UAA200612575A patent/UA89181C2/ru unknown
- 2005-05-31 DK DK10010080.9T patent/DK2292267T3/da active
- 2005-05-31 KR KR1020067025295A patent/KR101256417B1/ko not_active Expired - Fee Related
- 2005-05-31 PL PL07019644T patent/PL1891973T3/pl unknown
- 2005-05-31 SI SI200500163A patent/SI21784A/sl not_active IP Right Cessation
- 2005-05-31 PL PL379660A patent/PL379660A1/pl not_active Application Discontinuation
- 2005-05-31 AU AU2005247108A patent/AU2005247108B2/en active Active
- 2005-05-31 JP JP2007513837A patent/JP5049120B2/ja not_active Expired - Fee Related
-
2006
- 2006-03-14 US US11/375,308 patent/US20060154934A1/en not_active Abandoned
- 2006-04-18 US US11/405,888 patent/US20060205702A1/en not_active Abandoned
- 2006-04-21 US US11/409,157 patent/US20060189651A1/en not_active Abandoned
- 2006-11-28 EC EC2006007033A patent/ECSP067033A/es unknown
- 2006-11-28 NO NO20065477A patent/NO20065477L/no not_active Application Discontinuation
- 2006-11-28 NO NO20065476A patent/NO20065476L/no not_active Application Discontinuation
- 2006-11-28 NO NO20065478A patent/NO334337B1/no active Protection Beyond IP Right Term
- 2006-11-28 EC EC2006007036A patent/ECSP067036A/es unknown
- 2006-11-28 EC EC2006007038A patent/ECSP067038A/es unknown
- 2006-11-28 EC EC2006007035A patent/ECSP067035A/es unknown
- 2006-11-28 NO NO20065483A patent/NO20065483L/no not_active Application Discontinuation
- 2006-11-28 NO NO20065482A patent/NO338621B1/no not_active IP Right Cessation
- 2006-11-28 NO NO20065479A patent/NO20065479L/no not_active Application Discontinuation
- 2006-11-28 EC EC2006007037A patent/ECSP067037A/es unknown
- 2006-11-28 EC EC2006007034A patent/ECSP067034A/es unknown
- 2006-11-29 ZA ZA200609989A patent/ZA200609989B/xx unknown
- 2006-11-29 ZA ZA200609990A patent/ZA200609990B/en unknown
- 2006-11-29 ZA ZA200609986A patent/ZA200609986B/en unknown
- 2006-11-29 IL IL179687A patent/IL179687A/en active IP Right Grant
- 2006-11-29 ZA ZA200609985A patent/ZA200609985B/xx unknown
- 2006-11-29 IL IL179689A patent/IL179689A/en not_active IP Right Cessation
- 2006-11-29 IL IL179684A patent/IL179684A/en not_active IP Right Cessation
- 2006-11-29 ZA ZA200609987A patent/ZA200609987B/en unknown
-
2007
- 2007-03-23 US US11/726,982 patent/US20070167489A1/en not_active Abandoned
-
2008
- 2008-02-15 US US12/070,298 patent/US20080146603A1/en not_active Abandoned
- 2008-12-16 US US12/335,915 patent/US20090093503A1/en not_active Abandoned
- 2008-12-16 US US12/335,849 patent/US20090099148A1/en not_active Abandoned
- 2008-12-19 US US12/339,263 patent/US20090111785A1/en not_active Abandoned
-
2009
- 2009-03-16 CY CY20091100290T patent/CY1108885T1/el unknown
- 2009-03-17 US US12/405,613 patent/US20090176751A1/en not_active Abandoned
- 2009-03-20 CY CY20091100315T patent/CY1108902T1/el unknown
- 2009-06-09 CY CY20091100602T patent/CY1109139T1/el unknown
- 2009-10-28 US US12/607,429 patent/US20100048616A1/en not_active Abandoned
- 2009-10-28 US US12/607,409 patent/US20100048615A1/en not_active Abandoned
- 2009-11-12 US US12/616,960 patent/US20100056486A1/en not_active Abandoned
-
2010
- 2010-04-06 CY CY20101100311T patent/CY1109938T1/el unknown
- 2010-07-16 RU RU2010129940/15A patent/RU2465902C2/ru not_active IP Right Cessation
- 2010-09-03 HR HR20100489T patent/HRP20100489T1/hr unknown
- 2010-09-16 CY CY20101100844T patent/CY1110798T1/el unknown
- 2010-09-29 US US12/893,438 patent/US20110021476A1/en not_active Abandoned
- 2010-10-01 US US12/896,232 patent/US20110021478A1/en not_active Abandoned
- 2010-10-01 US US12/896,013 patent/US20110021477A1/en not_active Abandoned
-
2011
- 2011-03-22 CL CL2011000607A patent/CL2011000607A1/es unknown
- 2011-09-29 JP JP2011215066A patent/JP2012012407A/ja active Pending
- 2011-10-26 US US13/282,042 patent/US20120040943A1/en not_active Abandoned
- 2011-11-10 US US13/293,676 patent/US20120059031A1/en not_active Abandoned
- 2011-11-23 US US13/303,864 patent/US20120071452A1/en not_active Abandoned
- 2011-12-19 US US13/329,768 patent/US20120088743A1/en not_active Abandoned
-
2012
- 2012-03-02 US US13/411,003 patent/US20130035319A1/en not_active Abandoned
- 2012-07-06 JP JP2012152733A patent/JP5538485B2/ja not_active Expired - Fee Related
- 2012-08-02 US US13/565,413 patent/US20120302532A1/en not_active Abandoned
- 2012-08-17 US US13/588,124 patent/US20120309727A1/en not_active Abandoned
- 2012-08-17 US US13/588,106 patent/US20120309726A1/en not_active Abandoned
-
2013
- 2013-04-02 US US13/855,486 patent/US20140094442A1/en not_active Abandoned
- 2013-05-21 US US13/899,161 patent/US20130252928A1/en not_active Abandoned
- 2013-07-25 US US13/951,004 patent/US20130310354A1/en not_active Abandoned
-
2014
- 2014-01-29 US US14/167,809 patent/US20140148420A1/en not_active Abandoned
- 2014-06-16 US US14/305,701 patent/US20140296197A1/en not_active Abandoned
- 2014-08-28 US US14/471,819 patent/US20150202213A1/en not_active Abandoned
- 2014-09-11 HR HRP20140864TT patent/HRP20140864T1/hr unknown
- 2014-10-22 CY CY20141100869T patent/CY1115669T1/el unknown
- 2014-11-20 US US14/549,347 patent/US20150080359A1/en not_active Abandoned
-
2015
- 2015-02-19 NL NL300720C patent/NL300720I2/nl unknown
- 2015-02-24 FR FR15C0017C patent/FR15C0017I2/fr active Active
- 2015-02-27 HU HUS1500011C patent/HUS1500011I1/hu unknown
- 2015-02-27 NO NO2015007C patent/NO2015007I2/no not_active IP Right Cessation
- 2015-03-02 LT LTPA2015010C patent/LTC1763368I2/lt unknown
- 2015-03-03 CY CY2015006C patent/CY2015006I2/el unknown
- 2015-07-09 US US14/795,194 patent/US20150306079A1/en not_active Abandoned
- 2015-10-22 US US14/920,519 patent/US20160038470A1/en not_active Abandoned
-
2016
- 2016-03-24 US US15/080,475 patent/US20170049756A1/en not_active Abandoned
-
2017
- 2017-08-28 US US15/688,679 patent/US20180200234A1/en not_active Abandoned
-
2019
- 2019-02-07 US US16/269,705 patent/US20200009117A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008500988A5 (enExample) | ||
| JP2008500990A5 (enExample) | ||
| AU775588B2 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| RU2006147268A (ru) | Комбинации, включающие антимускариновые агенты и кортикостероиды | |
| JP6827948B2 (ja) | 呼吸器疾患の治療 | |
| HRP20100104T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i kortikosteroide | |
| JP2021063119A (ja) | 噴霧乾燥製剤 | |
| TWI475994B (zh) | 阿地銨之用途 | |
| JP6272836B2 (ja) | アベジテロールの新規の剤形および製剤 | |
| US20100329996A1 (en) | Novel Combination of Therapeutic Agents | |
| JP2006502207A (ja) | 作用期間が延長された新規ベータミメティックス、それらの製造方法及び薬剤としてのそれらの使用 | |
| TW200816993A (en) | Organic compounds | |
| MX2013009525A (es) | Combinacion de glicopirrolato y un beta2-agonista. | |
| EP3143987A1 (en) | Pharmaceutical formulation comprising a phosphodiesterase inhibitor | |
| IL271132B1 (en) | Dry powder aclidinium salt pharmaceutical composition for treatment of copd | |
| CN103582477A (zh) | 包含芜地溴铵和皮质类固醇的组合 | |
| US20090181935A1 (en) | Compositions comprising an antimuscarinic and a long-acting beta-agonist | |
| US20080261932A1 (en) | Methods and compositions for the prevention and/or treatment of an exacerbation of asthma | |
| HRP20120678T1 (hr) | Farmaceutski pripravci zasnovani na antagonistima kininskog b2 receptora i kortikosteroidima te njihova upotreba | |
| HK40058742B (zh) | 呼吸性疾病的治疗 | |
| TW201302195A (zh) | 阿地銨（ａｃｌｉｄｉｎｉｕｍ）之新用途 | |
| TW201341364A (zh) | 5-(2-{[6-(2,2-二氟-2-苯基乙氧基)己基]胺基}-1-(R)-羥乙基)-8-羥基喹啉-2(1H)-酮半萘二磺酸鹽之結晶多形體、其β型結晶多形體、包含其之藥學組成物、包含其之組合物及使用其製造藥劑之用途 |